Omnicell, Inc. (NASDAQ:OMCL) is set to announce third quarter earning results on Tuesday 27th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, OMCL to report 3Q20 income of $ 0.49 per share.
For the full year, analysts anticipate top line of $ 874.11 million, while looking forward to income of $ 2.24 per share bottom line.
The Company Outlook
Earnings for 3Q20 are anticipated in a range of $ 0.44 ~ $ 0.52 per share, while revenues are expected in a range of $ 204.00 million ~ $ 212.00 million
Full Year 2020 topline are forecasted in a range of$ 1,000.00 million ~ $ 1,020.00 million, where as bottomline are predicted in a range of $ 2.96 ~ $ 3.16 per share
Click Here For More Historical Outlooks Of Omnicell, Inc.
Previous Quarter Performance
Omnicell, Inc. announced income for the second quarter of $ 0.37 per share, from the revenue of $ 199.62 million. The quarterly earnings fell 44.78 percent while revenues shrunk 8.18 percent compared with the same quarter last year.
According to street consensus, OMCL was expected to report 2Q20 income of $ 0.23 per share from revenue of $ 182.42 million. The bottom line results beat street analysts by $ 0.14 or 60.87 percent, at the same time, top line results outshined analysts by $ 17.20 million or 9.43 percent.
Stock Performance
Shares of Omnicell, Inc. traded up $ 0.84 or 1.00 percent on Friday, reaching $ 84.47 with volume of 854.10 thousand shares. Omnicell, Inc. has traded high as $ 84.58 and has cracked $ 82.96 on the downward trend
According to the previous trading day, closing price of $ 84.47, representing a 54.19 % increase from the 52 week low of $ 54.24 and a 11.83 % decrease over the 52 week high of $ 94.85.
The company has a market capital of $ 3.61 billion and is part of the Technology sector and Health Information Services industry.
Conference Call
Omnicell, Inc. will be hosting a conference call at 4:30 PM eastern time on 27th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.omnicell.com
Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence.
